• General
    Information
    • Welcome Message
    • NACLC 2020 Virtual FAQs
    • Committees
    • Disclosures
    • CME Information
    • CME Credit & Attendance Certificates
    • Press & Media
    • Contact Us
  • Program
  • Advertising,
    Promotion & Exhibits
    • Promotion & Advertising
    • Exhibits
    • Industry & Satellite Symposia
  • Registration
    Now Closed

  • Access the
    Virtual Platform

    • Welcome Message
    • NACLC 2020 Virtual FAQs
    • Committees
    • Disclosures
    • CME Information
    • CME Credit & Attendance Certificates
    • NACLC 2020 Virtual Platform
    • Contact Us
    • Press & Media
    • Registration
    • Promotion & Advertising
    • Exhibits
    • Industry & Satellite Symposia
    • Call for Abstracts
    • Program at a Glance
MENU
  • Home
  • Join Mailing List
  • IASLC.org
  • General
    Information
    • Welcome Message
    • NACLC 2020 Virtual FAQs
    • Committees
    • Disclosures
    • CME Information
    • CME Credit & Attendance Certificates
    • Press & Media
    • Contact Us
  • Program
  • Advertising,
    Promotion & Exhibits
    • Promotion & Advertising
    • Exhibits
    • Industry & Satellite Symposia
  • Registration
    Now Closed

  • Access the
    Virtual Platform

  • Home
  • Join Mailing List
  • IASLC.org
  • #NACLC20
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
Conquering Thoracic Cancers Worldwide
  • General
    Information
    • Welcome Message
    • NACLC 2020 Virtual FAQs
    • Committees
    • Disclosures
    • CME Information
    • CME Credit & Attendance Certificates
    • Press & Media
    • Contact Us
  • Program
  • Advertising,
    Promotion & Exhibits
    • Promotion & Advertising
    • Exhibits
    • Industry & Satellite Symposia
  • Registration
    Now Closed

  • Access the
    Virtual Platform

Get Tickets!

CALL FOR ABSTRACTS

  • Call for Abstracts

Tweets by IASLC

Abstract Submission for NACLC 2020 Now Closed

Important Deadlines

Abstract Submission Now Closed
Abstract Submission Deadline July 31, 2020 (23:59 PST)
Abstract Notifications SENT (August 18)
Abstract Title Release September 18, 2020
Abstract (Full) Release October 13, 2020

Abstract Submission Guidelines
  • Abstracts must be submitted electronically and online
  • Abstracts will be accepted in English only
  • The abstract title must not exceed 125 characters in length
  • Abstracts must not exceed 400 words in length (not including title and authors)
  • Tables may be included and each will count as 100 words
  • A maximum of 2 images may be included; each will count as 100 words
  • Tables, images and graphs must be uploaded in JPG or TIFF format at 300 dpi and 100% size. Any higher resolution is acceptable.
  • Abstracts must be structured with the following:
    • Background
    • Methods
    • Results
    • Conclusion
  • The presenting author of an accepted abstract must be registered by September 18, 2020
  • There is no fee for submitting an abstract
  • There is no limit to the number of co-authors per abstract
  • There is no limit to the number of abstracts you may submit
  • Encore abstracts will be accepted
  • Trial-in-progress abstracts will be accepted
  • Special consideration will be given to authors < 4 years from completion of fellowship training (no proof required)
Submission Categories
  • Community Practice
  • Medical Oncology
  • Mesothelioma/Other Thoracic Malignancies
  • Nursing & Allied Health
  • Pathology
  • Patient Advocacy
  • Prevention, Smoking Cessation, Screening and Early Detection
  • Pulmonology
  • Radiation Oncology
  • Surgery
  • Translational Science
Contact

For any program and abstract related questions, please contact naclc2020-program at icsevents.com.



  • Stay Connected

    Keep up to date with Conference News & Alerts.
    Sign Up


     
    #NACLC20
© 2020 International Association for the Study of Lung Cancer – IASLC NACLC 2020 | Privacy Notice

Conference Newsletter
Subscribe to the Newsletter to receive important information about the upcoming Conference.
Thank you! We look forward to connecting soon.
Click here to close this window
Whoops, looks like there was an issue with one of the fields above - please review above.
X